Stock Market News

H.C. Wainwright maintains buy rating on Sana Biotechnology stock

Jun 24, 2025 - 12:54
 0
H.C. Wainwright maintains buy rating on Sana Biotechnology stock
Read More

Tags:

Previous Article

Compass Pathways stock holds Buy rating on positive depression trial

Next Article

H.C. Wainwright reiterates buy rating on Redwire stock after acquisition

Related Posts

Wall Street ends up with Nvidia; appeals court reinstates Trump tariffs

Wall Street ends up with Nvidia; appeals court reinstat...

May 29, 2025  0

Crypto stocks rise following Circle's successful IPO

Crypto stocks rise following Circle's successful IPO

Jun 6, 2025  0

Marathon assessing damage at Texas City refinery, sources say

Marathon assessing damage at Texas City refinery, sourc...

Jun 21, 2025  0